Ratings by Nephron (Chris Pasquale)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/23/2026 | Boston Scientific | BSX | Upgrade | Buy (Hold) |
64.87 (44.55) |
-31.32% | Details | |
| 2/12/2026 | Inspire Medical Systems | INSP | Downgrade | Hold (Buy) |
68.21 (50.33) |
-26.21% | Details | |
| 1/16/2026 | Penumbra | PEN | Downgrade | Hold (Buy) |
313.43 (317.68) |
1.36% | Details | |
| 12/8/2025 | Boston Scientific | BSX | Downgrade | Hold (Buy) |
97.52 (64.87) |
-33.48% | Details | |
| 12/8/2025 | Medtronic, Inc. | MDT | Upgrade | Buy (Hold) |
101.36 (83.11) |
-18.01% | Details | |
| 11/24/2025 | Inspire Medical Systems | INSP | Upgrade | Buy (Hold) |
89.87 (68.21) |
-24.1% | Details | |
| 8/7/2025 | Tandem Diabetes Care | TNDM | Downgrade | Hold (Buy) |
14.39 (15.17) |
5.42% | Details | |
| 8/5/2025 | Inspire Medical Systems | INSP | Downgrade | Hold (Buy) |
126.10 (89.87) |
-28.73% | Details | |
| 7/30/2025 | Penumbra | PEN | Upgrade | Buy (Hold) |
227.15 (313.43) |
37.98% | Details | |
| 7/21/2025 | Edwards Lifesciences | EW | Upgrade | Buy (Hold) |
76.49 (91.22) |
19.26% | Details | |
| 5/30/2025 | Cooper Companies | COO | Downgrade | Hold (Buy) |
79.96 (70.97) |
-11.24% | Details | |
| 8/29/2024 | Cooper Companies | COO | Upgrade | Buy (Hold) |
94.54 (79.96) |
-15.42% | Details | |
| 7/25/2024 | Edwards Lifesciences | EW | Downgrade | Hold (Buy) |
86.95 (76.49) |
-12.03% | Details | |
| 12/14/2023 | Zimmer Biomet | ZBH | Upgrade | Buy (Hold) |
117.90 (91.56) |
-22.34% | Details | |
| 7/21/2023 | Inari Medical Inc. | NARI | New Coverage | Buy (N/A) |
56.23 (79.97) |
42.22% | Details | |
| 7/21/2023 | Penumbra | PEN | New Coverage | Hold (N/A) |
305.86 (317.68) |
3.86% | Details | |
| 7/12/2022 | Zimmer Biomet | ZBH | New Coverage | Hold (N/A) |
103.30 (91.56) |
-11.36% | Details | |
| 7/12/2022 | ViewRay Inc. | VRAY | New Coverage | Hold (N/A) |
2.82 (0.03) |
-98.94% | Details | |
| 7/12/2022 | Tandem Diabetes Care | TNDM | New Coverage | Buy (N/A) |
56.73 (15.17) |
-73.26% | Details | |
| 7/12/2022 | Stryker | SYK | New Coverage | Buy (N/A) |
197.43 (329.56) |
66.92% | Details | |
| 7/12/2022 | Procept BioRobotics Corp | PRCT | New Coverage | Buy (N/A) |
30.97 (20.47) |
-33.9% | Details | |
| 7/12/2022 | Insulet Corporation | PODD | New Coverage | Buy (N/A) |
230.82 (160.55) |
-30.44% | Details | |
| 7/12/2022 | Nevro Corp | NVRO | New Coverage | Hold (N/A) |
46.60 (5.84) |
-87.47% | Details | |
| 7/12/2022 | Inspire Medical Systems | INSP | New Coverage | Buy (N/A) |
193.86 (50.33) |
-74.04% | Details | |
| 7/12/2022 | Edwards Lifesciences | EW | New Coverage | Buy (N/A) |
96.88 (91.22) |
-5.84% | Details | |
| 7/12/2022 | DexCom | DXCM | New Coverage | Buy (N/A) |
78.43 (74.45) |
-5.07% | Details | |
| 7/12/2022 | Cardiovascular Systems | CSII | New Coverage | Hold (N/A) |
14.24 (20.00) |
40.45% | Details | |
| 7/12/2022 | Cooper Companies | COO | New Coverage | Hold (N/A) |
304.56 (70.97) |
-76.7% | Details | |
| 7/12/2022 | Boston Scientific | BSX | New Coverage | Buy (N/A) |
37.51 (44.55) |
18.77% | Details | |
| 7/12/2022 | Axonics Modulation Technologies Inc. | AXNX | New Coverage | Buy (N/A) |
61.25 (70.98) |
15.89% | Details | |
| 7/12/2022 | AxoGen, Inc. | AXGN | New Coverage | Buy (N/A) |
8.14 (40.59) |
398.65% | Details | |
| 7/12/2022 | Alcon Inc. | ALC | New Coverage | Buy (N/A) |
70.62 (67.57) |
-4.32% | Details | |
| 7/12/2022 | Abbott Labs | ABT | New Coverage | Hold (N/A) |
108.89 (93.88) |
-13.78% | Details | |
| 7/12/2022 | ABIOMED | ABMD | New Coverage | Hold (N/A) |
262.07 (381.02) |
45.39% | Details |
